Key result
Supraventricular tachycardia affects approximately 2-3% of the population and is a usually paroxysmal, rarely life-threatening arrhythmia that can negatively impact quality of life.
Key points are not available for this paper at this time.
Design
Review
SVT's QoL burden warrants clinical awareness; leaves open need for updated prospective management trials.
Supraventricular tachycardia (SVT) describes a regular narrow complex tachycardia (NCT) (usually > 100bpm) with a QRS duration of 120ms or less. 1 SVT is a relatively common arrhythmia affecting approximately 2-3 per cent of the population; it is usually paroxysmal and rarely life-threatening but can impact on quality of life due to troublesome symptoms. 2
No takes yet. Share an insight, caveat, or question.
Tara Meredith (2012) studied this question. Supraventricular tachycardia affects approximately 2-3% of the population and is a usually paroxysmal, rarely life-threatening arrhythmia that can negatively impact quality of life.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: